SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN)
CUSIP: 868459108
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 57,671,650
- Total 13F shares
- 59,473,450
- Share change
- +324,270
- Total reported value
- $1,874,807,260
- Put/Call ratio
- 0%
- Price per share
- $31.52
- Number of holders
- 292
- Value change
- +$9,630,477
- Number of buys
- 160
- Number of sells
- 114
Quarterly Holders Quick Answers
What is CUSIP 868459108?
CUSIP 868459108 identifies SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 868459108:
Top shareholders of SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
15%
from 13D/G
|
9,684,552
|
$317,169,082 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
11%
|
6,163,892
|
$201,867,464 | — | 31 Mar 2025 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
9%
|
5,196,000
|
$170,169,000 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
5%
|
2,903,727
|
$95,094,446 | — | 31 Mar 2025 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
4.7%
|
2,699,667
|
$88,414,000 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
3.7%
|
2,145,350
|
$70,260,213 | — | 31 Mar 2025 | |
| Stephens Investment Management Group LLC |
13F
|
Company |
3%
|
1,738,482
|
$56,935,286 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2.7%
|
1,585,722
|
$51,932,396 | — | 31 Mar 2025 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
2.5%
|
1,440,644
|
$47,182,000 | — | 31 Mar 2025 | |
| GW&K Investment Management, LLC |
13F
|
Company |
2.4%
|
1,382,441
|
$45,275,000 | — | 31 Mar 2025 | |
| Polar Capital Holdings Plc |
13F
|
Company |
2.4%
|
1,362,340
|
$44,616,635 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
1,326,619
|
$43,456,798 | — | 31 Mar 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
2%
|
1,135,312
|
$37,181,469 | — | 31 Mar 2025 | |
| Aristotle Capital Boston, LLC |
13F
|
Company |
1.5%
|
872,688
|
$28,580,522 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.4%
|
824,155
|
$26,991,076 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1.3%
|
746,149
|
$24,436,380 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.2%
|
706,772
|
$23,146,784 | — | 31 Mar 2025 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
1.2%
|
672,518
|
$22,024,965 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.1%
|
649,838
|
$21,282,241 | — | 31 Mar 2025 | |
| ASHFORD CAPITAL MANAGEMENT INC |
13F
|
Company |
0.98%
|
566,556
|
$18,554,709 | — | 31 Mar 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.94%
|
543,913
|
$17,566,806 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.92%
|
530,631
|
$17,378,165 | — | 31 Mar 2025 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.9%
|
520,678
|
$17,052,205 | — | 31 Mar 2025 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.89%
|
515,889
|
$16,895,365 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.88%
|
509,360
|
$16,681,541 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.84%
|
483,079
|
$15,820,838 | — | 31 Mar 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.81%
|
467,881
|
$15,323,103 | — | 31 Mar 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.78%
|
452,684
|
$14,825,413 | — | 31 Mar 2025 | |
| Krensavage Asset Management, LLC |
13F
|
Company |
0.75%
|
431,986
|
$14,148,000 | — | 31 Mar 2025 | |
| Pacer Advisors, Inc. |
13F
|
Company |
0.7%
|
403,628
|
$13,218,817 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.67%
|
385,501
|
$12,625,167 | — | 31 Mar 2025 | |
| Tributary Capital Management, LLC |
13F
|
Company |
0.58%
|
331,979
|
$10,872,312 | — | 31 Mar 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.55%
|
318,903
|
$10,444,073 | — | 31 Mar 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.53%
|
306,322
|
$10,032,047 | — | 31 Mar 2025 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.47%
|
269,480
|
$8,701,509 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.45%
|
260,061
|
$8,516,998 | — | 31 Mar 2025 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.44%
|
256,406
|
$8,397,297 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.43%
|
250,316
|
$8,197,849 | — | 31 Mar 2025 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.42%
|
244,099
|
$7,994,165 | — | 31 Mar 2025 | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD |
13F
|
Company |
0.38%
|
219,731
|
$7,196,190 | — | 31 Mar 2025 | |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.35%
|
201,965
|
$6,614,354 | — | 31 Mar 2025 | |
| THIRD AVENUE MANAGEMENT LLC |
13F
|
Company |
0.33%
|
189,493
|
$6,205,896 | — | 31 Mar 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.3%
|
172,259
|
$5,641,482 | — | 31 Mar 2025 | |
| SYSTEMATIC FINANCIAL MANAGEMENT LP |
13F
|
Company |
0.29%
|
166,504
|
$5,453,020 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.29%
|
165,323
|
$5,414,302 | — | 31 Mar 2025 | |
| GREAT LAKES ADVISORS, LLC |
13F
|
Company |
0.28%
|
163,580
|
$5,357,245 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.28%
|
161,514
|
$5,289,584 | — | 31 Mar 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.26%
|
152,352
|
$4,989,526 | — | 31 Mar 2025 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.26%
|
149,489
|
$4,895,765 | — | 31 Mar 2025 | |
| Trexquant Investment LP |
13F
|
Company |
0.25%
|
144,494
|
$4,732,179 | — | 31 Mar 2025 |
Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) as of Q2 2025
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.